Cipla has launched an innovative combination ... tenofovir 300 mg and emtricitabine 200mg comprise the drug Viraday. Viraday, one tablet of which alone effectively treats a HIV infected person ...

Learn more› By Roderick Scott and Ryan Whitwam After a new round of testing, we’ve added the 2024 Amazon Fire HD 8 tablet as our budget pick and added Samsung’s Galaxy Tab S10+ to the ...

Cipla‘s shares were soaring on Thursday after one of the company’s plants was virtually cleared by the U.S. Food and Drug ...

Shares of Cipla Ltd advanced 3 per cent in Monday's trade after the drugmaker announced a VAI status for its Goa unit, which ...

Cipla’s revenue reached Rs. 7,051 crore, reflecting a 7% y-o-y increase and a 6% q-o-q rise, meeting our expectations. EBITDA stood at Rs. 1,886 crore with 15% y-o-y growth; it slightly missed ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

When looking for the best tablet for kids, you’ll want to consider the main ways your child will use device, as well as your budget and the tablet’s operating system. There are four main types ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Drug major Cipla Ltd said its Vice Chairman and Non-Executive Director MK Hamied has resigned from the company due to "age and health". "Vide letter dated 3rd September 2024, effective close of ...

Oct 30 (Reuters) - Indian shares fell on Wednesday, dragged down by high weightage financials and as drugmaker Cipla extended its post-results losses. Nine of the 13 major sectors logged losses.

10-May-24 02-Aug-24 02-Aug-24 13 Rs.13.0000 per share(650%)Final Dividend 12-May-23 21-Jul-23 21-Jul-23 8.5 Rs.8.5000 per share(425%)Final Dividend 27-Jul-22 10-Aug-22 08-Aug-22 5 Rs.5.0000 per ...

Cipla's consolidated revenue from operations stood at ₹7,051.02 crores during the quarter ended September from ₹6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5%. The firm ...